Why the study?
Does immunosuppressive therapy improve haemodynamic and histologic outcomes in a patient with giant cell myocarditis?
Does immunosuppressive therapy improve haemodynamic and histologic outcomes in a patient with giant cell myocarditis?
Immunosuppressive therapy may be lifesaving and lead to dramatic haemodynamic and histologic improvement in patients with giant cell myocarditis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for immunosuppression in giant cell myocarditis; prospective trials needed before clinical adoption.
Giant cell myocarditis is a rare entity of unknown aetiology with a rapidly fatal course unresponsive to treatment. We describe below a patient with biopsy-proven gaint cell myocarditis who underwent sustained haemodynamic and histologic improvement with immunoSuppressive therapy. Giant cell myocarditis must be suspected in patients with rapidly progressive heart failure. If the clinical diagnosis is confirmed by the finding of multinucleated cells in the myocardium, institution of immunoSuppressive therapy may be lifesaving.
No takes yet. Share an insight, caveat, or question.
Costanzo-Nordin et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: